Next Article in Journal
Organocatalytic Oxidative Dehydrogenation of Dihydroarenes by Dioxygen Using 2,3-Dichloro-5,6-dicyano-benzoquinone (DDQ) and NaNO2
Next Article in Special Issue
Biological and Pharmacological Activities of Squalene and Related Compounds: Potential Uses in Cosmetic Dermatology
Previous Article in Journal
Gastric and Duodenal Antiulcer Activity of Alkaloids: A Review
Previous Article in Special Issue
Bioactive Pentacyclic Triterpenes from the Stems of Combretum laxum
Article

A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex)

1
Carl Gustav Carus-Institut, Am Eichhof 30, D-75223 Niefern-Öschlbronn, Germany
2
Betulin-Institut, Blumenstrasse 24, D-64297 Darmstadt, Germany
*
Author to whom correspondence should be addressed.
Molecules 2008, 13(12), 3224-3235; https://doi.org/10.3390/molecules13123224
Received: 31 October 2008 / Revised: 10 December 2008 / Accepted: 17 December 2008 / Published: 18 December 2008
(This article belongs to the Special Issue Triterpenes and Triterpenoids 2013)
During the last two decades triterpenes have attracted attention because of their pharmacological potential. Triterpene extract (TE) from outer bark of birch consisting mainly of betulin is able to form an oleogel which was successfully tested in the treatment of actinic keratosis. Some aspects of TE in vitro pharmacology are already known. Now we show preliminary pharmacokinetics of betulin and results of a subchronic toxicity study of TE in rats and dogs. Because of poor aqueous solubility of the TE-triterpenes (< 0.1 μg/mL respectively), for pharmacokinetic studies it was suspended in sesame oil (rats, i.p.) and PEG 400 / 0.9 % NaCl (dogs, s.c.). I.p. administered, betulin, the main component of TE, shows time dependency over a period of 4 h and reaches a dose-independent serum level of 0.13 μg/mL. Dose dependency was observed with s.c. administration. At 300 mg/kg a maximum plasma concentration of 0.33 μg/mL betulin was detected after 28 daily applications. The subchronic toxicity study showed no toxicity of TE in rats (i.p.) and dogs (s.c.). In conclusion, triterpene extract from birch bark is safe, its betulin is bioavailable and in addition to published triterpene biological activities TE provides high potential for further pharmaceutical and pharmacological research. View Full-Text
Keywords: Triterpene extract; Betulin; Preliminary pharmacokinetics; Subchronic toxicity Triterpene extract; Betulin; Preliminary pharmacokinetics; Subchronic toxicity
Show Figures

Graphical abstract

MDPI and ACS Style

Jäger, S.; Laszczyk, M.N.; Scheffler, A. A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex). Molecules 2008, 13, 3224-3235. https://doi.org/10.3390/molecules13123224

AMA Style

Jäger S, Laszczyk MN, Scheffler A. A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex). Molecules. 2008; 13(12):3224-3235. https://doi.org/10.3390/molecules13123224

Chicago/Turabian Style

Jäger, Sebastian, Melanie N. Laszczyk, and Armin Scheffler. 2008. "A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex)" Molecules 13, no. 12: 3224-3235. https://doi.org/10.3390/molecules13123224

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop